Our Solutions   Iritero 40 Injection

Iritero 40 Injection

Iritero 40 Injection

*To be consumed as directed by physician.

Therapies:

Anti Neoplastics

Composition:

Irinotecan (40 mg)

About Iritero 40 Injection

Iritero 40 Injection is an anticancer drug widely used in the treatment of colorectal cancer, including cancers of the colon and rectum. It contains Irinotecan, a chemotherapy medicine that belongs to the class of topoisomerase I inhibitors. The injection works by interfering with the growth and multiplication of cancer cells, thereby slowing or stopping the spread of cancer in the body. It may be used alone or in combination with other anticancer medicines based on the patient’s condition and treatment plan. Iritero 40 Injection is administered under the supervision of a qualified physician in a hospital or clinical setting.

Iritero 40 Injection

*To be consumed as directed by physician.


Usage Instructions

  • Before receiving Iritero 40 Injection, the patient should follow the treatment plan and schedule prescribed by the oncologist carefully.
  • This injection should be administered through IV into the vein by a certified physician in a clinical setting and should not be self-administered.
  • The dosage and frequency of administration may vary depending on the type and severity of cancer, body condition, and response to treatment.
  • Patients are advised to stay well hydrated and inform the doctor immediately if they experience severe diarrhoea, fever, vomiting, or unusual weakness during the treatment.
  • Regular monitoring through blood tests may also be required during therapy.

Benefits and Use

  • Iritero 40 Injection is used in the treatment of advanced or metastatic colorectal cancer, including cancers affecting the colon and rectum.
  • It helps slow down the growth and spread of cancer cells by interfering with their ability to multiply.
  • This injection may be used alone or in combination with other chemotherapy medicines to improve treatment effectiveness.
  • By helping control tumour progression, Iritero 40 Injection may support better disease management and improve the patient’s overall treatment outcome under medical supervision.

Safety Information

  • Pregnancy
  • Iritero 40 Injection is not recommended during pregnancy as it may harm the unborn baby.
  • Breastfeeding
  • Breastfeeding should be avoided during treatment with Iritero 40 Injection unless advised otherwise by the doctor.
  • Kidney
  • Iritero 40 Injection should be used with caution in patients with kidney problems and under proper medical supervision.
  • Liver
  • Patients with liver disorders should use Iritero 40 Injection carefully, as dose adjustments and regular monitoring may be required.
  • Alcohol
  • Alcohol consumption should be avoided during treatment with Iritero 40 Injection as it may increase the risk of side effects.

Ingredients

Irinotecan (40 mg)

How to Use

  • Iritero 40 Injection is administered by a trained physician in a hospital or clinical environment.
  • It is given slowly into the vein as an intravenous infusion, usually according to the treatment schedule recommended by the doctor.
  • Patients should avoid self-administration and attend all scheduled appointments for proper monitoring during the treatment course.

Storage Information

Store below 25°C